Skip to main content

UBS Group AG

Position in HAE — Haemonetics Corp

CIK 1610520 ZURICH, V8

Position in HAE

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$29,680,133
-$13,574,978 QoQ
Shares Held
526,617
-2.4% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in HAE Over Time

Shares Held

Position Value (USD)

Derivatives in HAE

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$3,777,350
PutShares
77,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

UBS Group AG holds $5,241,938,219 across 132 Medical Devices names. HAE ranks #20 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HAE

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $29,680,133 526,617
2025-12-31 $43,255,111 539,677
2025-09-30 $70,798,309 1,452,571
2025-09-30 $3,777,350 77,500
2025-06-30 $64,894,957 869,789
2025-03-31 $26,442,962 416,097
2024-12-31 $15,031,336 192,512
2024-09-30 $1,932,816 24,046
2024-06-30 $1,555,819 18,806
2024-03-31 $4,960,029 58,114
2023-12-31 $6,164,159 72,087
2023-09-30 $3,983,532 44,469
2023-06-30 $5,948,560 69,868
2023-03-31 $4,866,692 58,812
2022-12-31 $3,401,532 43,249
2022-09-30 $442,329 5,975
2022-06-30 $329,549 5,056
2022-03-31 $1,255,295 19,856
2021-12-31 $1,773,604 33,439
2021-09-30 $241,347 3,419
2021-09-30 $1,270,620 18,000
2021-06-30 $246,167 3,694
2021-03-31 $2,012,277 18,127
2020-12-31 $2,779,106 23,403
2020-09-30 $3,194,396 36,612
2020-06-30 $512,462 5,722
2020-03-31 $1,147,485 11,514